Director, 10% Owner · Cocrystal Pharma, Inc. · Common Stock
Side
BUY
Value
$1,500
Shares
1,500
Price
$1
Executed
Nov 26, 2025
Disclosed
Nov 28, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 26 executedNov 28, 2025 disclosed
COCP · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Frost Phillip Md Et Al filed this Form 4 reporting a open-market purchase of COCP on Nov 26, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, 10% Owner
Frost Phillip Md Et Alcik:0000898860
Issuer
Cocrystal Pharma, Inc.cik:0001412486
Revision history · 0
No field has changed since this record was first ingested.
